technetium tc 99m dimercaptosuccinic acid has been researched along with ifosfamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anninga, JK; de Kraker, J; Hoefnagel, CA; Valdés Olmos, RA; van Royen, EA; van Tinteren, H | 1 |
| Morrison, SC; O'Donnell, JK | 1 |
| Akyuz, C; Caglar, M; Yarís, N | 1 |
3 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and ifosfamide
| Article | Year |
|---|---|
Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Tubules; Male; Neoplasms; Organotechnetium Compounds; Radioisotope Renography; Sensitivity and Specificity; Succimer; Technetium Tc 99m Dimercaptosuccinic Acid | 1994 |
Ifosfamide-induced alteration of technetium-99m-DMSA renal parenchymal imaging.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Infant; Kidney Diseases; Kidney Tubules; Pyelonephritis; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma, Embryonal; Technetium Tc 99m Dimercaptosuccinic Acid; Urinary Bladder Neoplasms | 1997 |
The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biological Transport; Child; Child, Preschool; Cisplatin; Creatinine; Cysteine; Female; Humans; Ifosfamide; Infant; Kidney; Male; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Tissue Distribution | 2001 |